Annual Rebalancing
EUR
Moderate Risk
1.7yr backtest
Analyse this portfolio

Performance Summary

Total Return+29.06%
Annualized Return+16.11%
Volatility+16.42%
Sharpe Ratio0.86
Max Drawdown+22.27%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Diversified global equity portfolio with 60% US tech & S&P 500, plus 40% in developed and emerging international markets via ETFs.
AssetTypeAllocationTER
XNAS.XETRA
Xtrackers Nasdaq 100 UCITS ETF 1C • IE00BMFKG444
ETF
40.0%0.2%
XDPU.XETRA
Xtrackers S&P 500 UCITS ETF 4C • IE000Z9SJA06
ETF
20.0%0.03%
IXUA.XETRA
iShares MSCI World ex-USA UCITS ETF USD (Acc) • IE000R4ZNTN3
ETF
20.0%0.15%
IS3N.XETRA
iShares Core MSCI Emerging Markets IMI UCITS • IE00BKM4GZ66
ETF
20.0%0.18%
Total100.0%0.15%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €12,906.4
Histogram of Monthly Returns
The portfolio had a positive return during 14 of the 22 months (64%)
Monthly Returns Heatmap
Best month: +11.3% • Worst month: -7.5% • Best year: 2026 (+19.3%) • Worst year: 2025 (+8.2%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+1.9%+1.2%-5.8%+11.3%+8.4%+1.6%-4.6%+3.0%+3.5%-1.4%--+19.3%
2025+1.2%-2.8%-7.5%-3.3%+7.1%+1.8%+4.9%-0.8%+3.9%+5.6%-1.4%+0.2%+8.2%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +22.27% • The longest drawdown period lasted for 6 months and was between February 2025 and September 2025. It reached a trough of -22.3%.

Detailed Metrics

Returns
Total Return
+29.06%
Annualized Return
+16.11%
Avg Monthly Return
+1.27%
Risk
Volatility (Annual)
+16.42%
Max Drawdown
+22.27%
Positive Months
64%
Average Drawdown
-4.2%
Risk-Adjusted
Sharpe Ratio
0.86
Risk-free rate: 2.0%
Sortino Ratio
0.81
Downside risk adjusted
Return/Volatility
0.98
Calmar Ratio
0.72
Return/Max Drawdown
Ulcer Index
5.42
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€12,906.4
Backtest Period
2025-01-30 to 2026-10-16
1.7 years
Rebalancing
annual
Base Currency
EUR